NEW YORK, May 24 (Reuters) - Privately held drugmaker Apotex Corp. said on Thursday it has launched a generic version of Pfizer Inc.’s (PFE.N) Norvasc blood-pressure drug, the second generic version of the once-blockbuster product.
Norvasc had been one of Pfizer’s biggest selling products. But Mylan Laboratories Inc. MYL.N began selling its generic version in March, and the arrival of generic versions is expected to dramatically cut into Pfizer’s sales.
Mylan signaled in its quarterly earnings report earlier on Thursday that another generic Norvasc, known as amlodipine, could be near the market.
((Reporting by Lewis Krauskopf; Reuters Messaging: Lewis.Krauskopf.email@example.com; firstname.lastname@example.org; 646-223-6082)) Keywords: APOTEX NORVASC/
C Reuters 2007. All rights reserved. Republication or redistribution ofReuters content, including by caching, framing or similar means, is expresslyprohibited without the prior written consent of Reuters. Reuters and the Reuterssphere logo are registered trademarks and trademarks of the Reuters group ofcompanies around the world.nN24463736